In sum, GLP-1 agonists associate with a reduced risk in CRC and a modest relative increase in thyroid cancer risk
The core mechanism difference: dual versus triple agonism Understanding why retatrutide outperforms Mounjaro requires understanding what the glucagon receptor actually does when activated alongside GLP-1 and GIP
Orforglipron In phase II, randomized, double-blind study, adults with overweight or obesity and without T2DM who took oral orforglipron (12, 24, 36, or 45 mg) daily for 36 weeks experienced a weight reduction of 9.414.7% [105]
Reconstitution involves mixing Retatrutide powder with bacteriostatic water to create a solution
GLP-1 drugs may also lower blood pressure in some people, potentially leading to other heat-related issues in people with low blood pressure
The positive reviews consistently highlight several themes